Purchase Order 36C26023P0102

Award Date 11/14/22
Potential Completion Date 11/14/23
Potential Value $33K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, NH 03801, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $49,748.73 firm-fixed-price delivery order contract to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to VA medical facilities nationwide. This delivery order is issued under Novocure's existing...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $16,582.91 firm-fixed-price delivery order contract to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy transducers, device rentals, and associated support services. This delivery order is issued under Novocure's $28.85 million, 5-year Federal Supply Schedule (FSS) contract...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order to Novocure Inc., a foreign-owned for-profit company, for the provision of Optune Plus Transducers. Novocure is the prime contractor and will deliver the medical equipment and services directly to the VA without subcontractors. The purchase order has a potential value of $126,000.00 and a period of performance ending on March 31, 2021. Novocure also holds a 5-year Federal Supply...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a delivery order contract to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, for the provision of Optune Plus transducers and related cancer therapy support services. The contract, valued at $49,748.73, has a completion date of September 8, 2024, and was issued under Novocure's existing 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a ceiling value of $28.85...
This is a federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy using its proprietary Tumor Treating Fields (TTFields) technology. The contract, valued at $49,748.73, was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) under its Federal Supply Schedule (FSS) program. The contract is for the provision of Novocure's Optune Plus transducers, device rentals, and related...
This federal contract award, with an ID of 36F79723D0016|36C24825N0133, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to the prime contractor Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $16,582.91 Firm Fixed Price contract is for the delivery of Optune Plus transducers, a proprietary cancer therapy device that uses Tumor Treating Fields (TTFields) technology. The contract has an ultimate completion date of...
This contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is for the provision of Optune Plus transducers, device rentals, and related support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, which has an award value of $49,748.73, is a delivery order issued under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, valued at up to $28.85 million. The contract does not...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $16,582.91 firm-fixed-price delivery order (Contract ID: 36F79723D0016|36C24523F0275) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The award is for the provision of Optune Plus transducers, model E0766, to support a veteran patient. Novocure's Optune system delivers alternating electric fields to disrupt solid tumor cancer cell division and is FDA-approved for the...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is a delivery order under the company's 5-year Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) with the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $16,582.91 firm fixed-price award is for the one-month rental of Novocure's Optune Plus transducers, which deliver the company's proprietary Tumor Treating Fields (TTFields) cancer therapy....
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a firm fixed-price delivery order contract to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the provision of the Optune Plus system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma, for VA patients. This delivery order is part of a larger $28.85 million...

The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm-fixed-price purchase order contract to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, for the procurement of Optune Plus Transducers. The $33,165.82 contract has an ultimate completion date of November 14, 2023. This contract award is not set aside for any specific business category.

Novocure is a manufacturer of the Optune line of Tumor Treating Fields (TTFields) therapy devices, which are FDA-approved for the treatment of glioblastoma and mesothelioma. The company provides its proprietary Optune system and associated equipment rentals, transducer arrays, and support services directly to VA medical facilities across the country. This contract award is issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, enabling the VA to efficiently obtain Novocure's cancer treatment technologies for its veteran patient population.

Generated 8/29/24, 9:41 AM